Stevia Corp, STEV, Profile, Summary

Stevia Corp. | STEV | Profile | Summary

Stevia Corp. (STEV) is a farm management company focused on Stevia agronomics from plant breeding to good agricultural practices to development of stevia derived products.

Stevia Corp. invests heavily in R&D and IP acquisition and manages its own propagation, nursery, and plantations as well as provides services to contract growers and other industry growers.

The Company was founded to deliver top quality agribusiness solutions in order to maximize the efficient mass production of stevia leaf and stevia derived products. The Company is headquartered in the US with farm operations/R&D in Vietnam, China, and Indonesia and planned operations in the US.

Read the comprehensive analysis: find out the ‘Target Price’, market dynamics, the opportunity and meet the excellent management team click here , download the full report!

INVESTMENT HIGHLIGHTS

Opportunity to invest in an early development stage, vertically-integrated stevia farm management company in an emerging, high growth market

The Company plans to be a “one stop shop” agribusiness solutions provider offering the full spectrum of farm management services

o Operate its own plantations, manage contract farms, and service industry growers (read Executive Summary)

o Expects to achieve positive EBITDA by the second quarter of 2013, growing to $3mm in annualized EBITDA by the end of 2013

(read full Investment Highlights)

o Positioned to become a global leader in the stevia industry that maximizes the efficient mass production of stevia leaf and stevia derived products

o Fastest growing product in the alternative sweetener market with 6,000 products across 35 countries

o Expected to eventually replace 20% of the sugar segment of global sweeteners or a $10 billion market opportunity

Our valuation analysis results in a target price of $1.20 per share which represents significant upside of over 4 times the current stock price(see Valuation)

The Company recently secured $500,000 in an equity private placement

and has access to $20 millionfrom Southridge Partners.

 

Global sweetener market is a $60 billion dollar industry! See the company’s growth plans, the advantages of Vertically Integrated Supply Chain and much more…full free report

 

MANAGEMENT TEAM

Strong Global Executive Team with highly recognized leadership skills, expertise and decades of experience in Three Continents, Four vibrant economic regions of the world (The United States, Europe, Latin America and Asia-Pacific).

George S. Blankenbaker (President)

Mr. Blankenbaker has been leading the development of high Reb-A Stevia farming in Vietnam, where he imported the Morita variety to trial in 2008 and in 2009 signed a contract to supply stevia leaf to PureCircle, the industry’s leading refiner. Mr. Blankenbaker first became involved in commercial agriculture in 2002 when he began working with the Agri-Food Veterinary Authority of Singapore (AVA) to provide strategically important food supplies to Singapore. Prior to that Mr. Blankenbaker co-wrote and co-presented a bid for the U.S. Navy Subsistence Prime Vendor (SPV) Contract valued at USD $197 million covering three zones of Japan, Singapore, and Diego Garcia. The contract was awarded in 2002 and the Singapore and Diego Garcia portion is currently supported by the Rong-Yao group, a partner company based in Singapore.

During the 1990s Mr. Blankenbaker was the Managing Director of a foodservice equipment company servicing South East Asia and was a partner of a holding company that established the first broadline foodservice distribution facility in Singapore which was also the first food distribution facility in Singapore to achieve both ISO 9000 and HACCP certification. Mr. Blankenbaker also traded commodities and was an independent consultant and analyst for Standard Chartered Bank and Reuters and was on the implementation team that established Globex in Singapore linking the Singapore International Monetary Exchange with the Chicago Board of Trade. Read more…

Rodney L. Cook (Director)

Dr. Pablo Erat (Director)

Thomas Ong (Director of Operations, Asia)

Dr. Zhang Ji (Chief Technical Advisor)

Dr. Nguyen Van Dan

(Technical Advisor – Vietnam R&D and Propagation Center)

Vincent Tan Meng Sheong (Director of Operations, China)

click here for Management Bios

Don’t miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoneywe received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Epic, EPOR, Market Summary, Profile

Epic (EPOR) Market Summary

Epic is a publicly traded company, since its founding in 1997, the company has focused on Research and Development of Healthcare products. Epic’s goal is to make a meaningful difference in the lives of millions of Americans who are suffering from chronic pains. (Note:-OxBridge has just released a comprehensive Marketing Intelligence Report on EPOR) see the full Report

AcuFABTM

The company has successfully developed a specially engineered fabric called AcuFABTM, which improves blood circulation to the pressure points and sore joints, providing great comfort and relief from chronic pains.

EPIC sells ‘the fabric’ to the Original Equipment Manufacturers (OEMs), these manufacturers make, various products using the AcuFabTM, and sell directly to consumers and healthcare institutions under their own Brand names.

AcuPADTM

EPIC also makes its own Branded products, with AcuFABTM, under the name AcuPADTM. AcuPADs are sold directly to healthcare institutions and consumers through the company’s website www.epiccor.com, Amazon.com and other distributors.

Business Model

Epic’s business model is similar to Intel’s famous “intel inside” model, where Intel supplies CPUs to companies like Dell and HP and these OEMs incorporate intel’s technology into their PCs and Laptops.

The Opportunity

Epic Corporation has a proprietary and patent protected manufacturing process for a fabric solution which offers great advantages to the surface tissue. In a world where we have major problems with sedentary lifestyles, poor eating habits, and healthcare issues, these solutions may be the answer for patients everywhere. What is most intriguing is that these products have some technological barriers to entry yet do not have to go through the rigorous FDA approval process.

Epic’s Solutions for Healthcare Crisis

American healthcare system is under severe strain and the healthcare costs are rising rapidly, Obesity and Diabetes increasing dramatically due to diet and sedentary life style. EPIC’s preventative solutions for chronic pains could provide relief from pain and financial burden. read the full Report

Don’t miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.